1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinico-morphological features of braf inhibition-induced proliferative skin lesions in cancer patients
    Journal Article

    Belum, V. R.; Rosen, A. C.; Jaimes, N.; Dranitsaris, G.; Pulitzer, M. P.; Busam, K. J.; Marghoob, A. A.; Carvajal, R. D.; Chapman, P. B.; Lacouture, M. E.
    Cancer (2015)

    Fulltext@MSK | Save
  • Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts
    Journal Article

    Katabi, N.; Ghossein, R.; Ho, A.; Dogan, S.; Zhang, L.; Sung, Y. S.; Antonescu, C. R.
    Human Pathology (2015)

    Fulltext@MSK | Save
  • Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival
    Journal Article

    De Remigis, A.; de Gruijl, T. D.; Uram, J. N.; Tzou, S. C.; Iwama, S.; Talor, M. V.; Armstrong, T. D.; Santegoets, Sjam; Slovin, S. F.; Zheng, L.; more...
    International Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Systemic therapy in advanced hepatocellular carcinoma
    Book Section

    Ang, C.; Owen, D.; Abou-Alfa, G. K.
    In Kee, S. T.; Murthy, R.; Madoff, D. C. (Eds.) Clinical Interventional Oncology (2014)

    Fulltext@MSK | Save
  • Utilizing microtubule dynamics inhibitor therapeutics in the management of patients with metastatic breast cancer
    Journal Article

    Seidman, A. D.; Brufsky, A.; Fornier, M. N.
    Clinical Breast Cancer (2014)

    Fulltext@MSK | Save
  • RTOG 0436: A phase III trial of cisplatin, paclitaxel and radiation with or without cetuximab in the nonoperative treatment of esophageal cancer
    Meeting Abstract

    Ilson, D.; Winter, K.; Suntharalingham, M.; Dicker, A.; Kachnic, L.; Konski, A.; Chakravarthy, A.; Anker, C.; Thakrar, H.; Horiba, N.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • The androgen receptor as a therapeutic target for castration-resistant prostate cancer
    Journal Article

    Feldman, J. L.; Rathkopf, D.; Morris, M. J.
    Current Clinical Urology (2014)

    Fulltext@MSK | Save
  • Systemic targeted therapy for recurrent and metastatic head and neck squamous cell cancer
    Book Section

    Fury, M. G.; Pfister, D. G.
    In Harrison, L. B.; Sessions, R. B.; Kies, M. S. (Eds.) Head and Neck Cancer: A Multidisciplinary Approach. 4th ed (2014)

    Fulltext@MSK | Save
  • Postoperative adjuvant therapy after resection of regionally advanced esophageal cancer
    Book Section

    Won, E.; Ilson, D. H.
    In Ferguson, M. K. (Eds.) Difficult Decisions in Thoracic Surgery: An Evidence-Based Approach. 3rd ed (2014)

    Fulltext@MSK | Save
  • Impairment of Treg suppression by GITR ligation is effective selectively in the context of a pro-inflammatory tumor microenvironment
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Schaer, D.; Yang, X.; Zhong, H.; Merghoub, T.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save